Search Results for: r3 stem

Recommended regenerative medicine reads: COVID-19 updates, Cornea Fix, Pubs

June 8, 2022 / By / Leave a Comment
2019nCoV-NP-cardio-myocytes

Another week and more great papers and interesting news in the regenerative medicine sphere including COVID-19 updates, stem cells for vision, and more. Rebuilding Corneas With Stem Cells Stem cell-based regenerative medicine arguably has shown the most promise for vision loss. A PR from Massachusetts Eye and Ear says: Doctors rebuild damaged corneas using patients’ …

Recommended regenerative medicine reads: COVID-19 updates, Cornea Fix, Pubs Read More »

CAR-T cells review: cancer & a critical look at possible uses in aging & COVID-19

June 8, 2022 / By / 2 Comments
CAR-T-cell-infographic

Introduction to CAR-T cells CAR-T cells are an exciting cutting-edge technology that has been garnering great interest including in the stem cell field. Potential therapeutic uses of CAR-T, which stands for Chimeric Antigen Receptor T-Cells (CAR-T), are being studied in clinical trials as immunotherapies to potentially fight cancer as well as many other diseases by …

CAR-T cells review: cancer & a critical look at possible uses in aging & COVID-19 Read More »

Updated FDA granted RMAT List (85)

FDA-RMAT

Today’s post includes a list of firms/products that have self-reported that they have received FDA regenerative medicine advanced therapy designation or RMAT. Sometimes people call these “r mat” with a space. As of December 12, 2023 there are 85 RMATs in the public domain. I also include FDA data on RMAT submissions via an FDA RMAT resource …

Updated FDA granted RMAT List (85) Read More »

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur

February 1, 2021 / By / 3 Comments
Right-To-Try-Debate-Roxland-Sandefur

Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, …

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur Read More »

Chat with Michael Werner of ARM on Cures Act regenerative medicine provisions

February 1, 2021 / By
Michael-Werner-Pic

One of the hottest topics in the world of stem cells this year has been the REGROW ACT and at a larger level the movement for changes in FDA oversight of investigational regenerative medicine therapies (see my past posts on it here), so the related provisions in the 21st Century Cures Act are stirring much …

Chat with Michael Werner of ARM on Cures Act regenerative medicine provisions Read More »

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit

February 1, 2021 / By / 7 Comments
GeneEditSummit

I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there …

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit Read More »

NAS Meeting on Human Germline Modification Taking Shape

February 1, 2021 / By / 4 Comments
NAS-CRISPR3

The US National Academy of Sciences (NAS) will hold a meeting on heritable human germline modification on December 1-3, 2015 in Washington, D.C. Invitations to the NAS meeting to individuals starting going out last week. The upcoming NAS meeting seeks to address these issues and discuss the possibility of a moratorium on clinical use of …

NAS Meeting on Human Germline Modification Taking Shape Read More »

Big push for 3-parent IVF technology in UK

February 1, 2021 / By / 3 Comments
3-person-technology-letter

A new piece came out yesterday on the Wellcome Trust Blog, strongly promoting approval of so-called “3-Parent IVF” or Mitochondrial Transfer technology by the UK Parliament. As I written in the past (here and here), my view is that this would be a mistake at this time. There is room for respectful disagreement on this issue between scientists, …

Big push for 3-parent IVF technology in UK Read More »

Putting the IP in iPS cells: patent war looming?

February 1, 2021 / By / 20 Comments
war

Will intellectual property (IP) wars over patent rights to one of the most exciting new stem cell technologies hold back getting novel therapies to patients such as IPS cells? Unfortunately, it’s very possible. Induced pluripotent stem (iPS) cells are very cool stem cells made from non-stem cells through a process called cellular reprogramming. iPS  cells …

Putting the IP in iPS cells: patent war looming? Read More »